Commonwealth legislation

Therapeutic Goods Act 1989 - Order under subsection 3(1) - Definition of British Pharmacopoeia (04/05/2009)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

This Order updates the definition of British Pharmacopoeia in the Therapeutic Goods Act 1989.

What it does:

Specifies that when the Act refers to the "British Pharmacopoeia", it means the British Pharmacopoeia 2009 (the official UK standards book for medicines)
The new definition takes effect on 1 June 2009

Why it matters: The Therapeutic Goods Act uses the British Pharmacopoeia as a benchmark for the quality, purity, and strength of medicines in Australia. By updating the reference to the 2009 edition, the law ensures that Australian therapeutic goods must meet current international standards.

Who it affects: This primarily affects pharmaceutical companies and manufacturers who must ensure their products comply with the standards set out in the 2009 British Pharmacopoeia.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods Act 1989 - Order under subsection 3(1) - Definition of British Pharmacopoeia (04/05/2009).

Therapeutic Goods Act 1989 - Order under subsection 3(1) - Definition of British Pharmacopoeia (04/05/2009)

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2

?xml version="1.0" encoding="utf-8" standalone="no"?>

View image in the official source

THERAPEUTIC GOODS ACT 1989

ORDER UNDER SUBSECTION 3(1) – DEFINITION OF BRITISH PHARMACOPOEIA

I, CHARLES MASKELL-KNIGHT, delegate of the Minister for Health and Ageing for the purposes of the exercise of the Minister’s power under the definition of “British Pharmacopoeia” in subsection 3(1) of the Therapeutic Goods Act 1989 (“the Act”) and acting under that provision, HEREBY SPECIFY that on and from 1 June 2009 the definition of “British Pharmacopoeia” in the Act shall be the British Pharmacopoeia 2009.

Dated this 4th day of May 2009

Signed

CHARLES MASKELL-KNIGHT

A/g National Manager

Therapeutic Goods Administration

(Delegate of the Minister for Health and Ageing)

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.